Topical tazarotene for the treatment of ectropion in ichthyosis.

Abstract

IMPORTANCE:

Ectropion is a complication of certain subtypes of ichthyosis and is often associated with substantial medical and cosmetic consequences. At present there is no standard of care for the treatment of ectropion in this population. Retinoids cause dyshesion and thinning of stratum corneum, thereby reducing hyperkeratosis that likely underlies ectropion in patients with ichthyosis. As such, retinoids provide a potential effective treatment for ectropion in this group of patients.

OBSERVATION:

We describe a patient with recessive ichthyosis for whom daily application of topical tazarotene produced rapid and persistent improvement of bilateral lower eyelid ectropion without adverse effects.

CONCLUSIONS AND RELEVANCE:

Additional studies will be necessary to more fully and systematically address the safety and efficacy of topical retinoids for the treatment of ectropion in patients with ichthyosis; however, this case illustrates that topical tazarotene and other retinoids provide a potential treatment option for ectropion in this population. We encourage clinicians to explore medical therapies as alternatives to surgical intervention for the treatment of ectropion in patients with ichthyosis.

• Authors: Brittany G Craiglow, Keith A Choate, Leonard M Milstone
• Journal: JAMA dermatology (JAMA Dermatol) Vol. 149 Issue 5 Pg. 598-600 (May 2013) ISSN: 2168-6084 [Electronic] United States
• PMID: 23677086 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Keratolytic Agents
• Nicotinic Acids
• tazarotene

Topics

• Administration, Cutaneous
• Aged
• Ectropion (drug therapy, etiology)
• Female
• Humans
• Ichthyosis (complications)
• Keratolytic Agents (administration & dosage)
• Nicotinic Acids (administration & dosage)